ChristyARussellMD

PubMed

• 2 citations
  Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2-, node-positive early breast ...
  Michael Crager, Sameera R Wijayawardana, Aaron M Gruver, Andrea Blacklock, Christy Russell, Frederick L Baehner, Francisco Sapunar> ;Breast Cancer Research. 2022 Nov 1
• 1 citations
  Discordance in Oncotype DX Breast Recurrence Score® Results for Bilateral Breast Cancer.
  Joshua A Bloom, Yurie Sekigami, Rebekah Young, Lisa Macera, Christy A. Russell, Yu Cao, Rachel J. Buchsbaum, Stephen P. Naber, Abhishek Chatterjee> ;Annals of Surgical Oncology. 2021 Jul 9
• ASO Visual Abstract: Discordance in Oncotype DX Breast Recurrence Score® Results for Bilateral Breast Cancer.
  Joshua A Bloom, Yurie Sekigami, Rebekah Young, Lisa Macera, Christy A. Russell, Yu Cao, Rachel J. Buchsbaum, Stephen P. Naber, Abhishek Chatterjee> ;Annals of Surgical Oncology. 2021 Jul 8
• 6 citations
  Expanding Criteria for Prognostic Stage IA in Hormone Receptor-Positive Breast Cancer
  Olga Kantor, Tari A. King, Steven Shak, Christy A. Russell, Armando E. Giuliano, Gabriel N. Hortobagyi, Harold J. Burstein, Eric P. Winer, Tanujit Dey, Joseph A. Spara...> ;Journal of the National Cancer Institute. 2021 May 19
• 9 citations
  Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer.
  Tal Sella, Shari Gelber, Philip D. Poorvu, Hee Jeong Kim, Laura S. Dominici, Yaileen D Guzman-Arocho, Laura C. Collins, Kathryn J. Ruddy, Rulla M. Tamimi, Jeffrey Pepp...> ;Breast Cancer Research and Treatment. 2021 Feb 1
• 5 citations
  Young-Onset Colon Cancer and Recurrence Risk by Gene Expression.
  George J. Chang, You Yny, Christy A. Russell, Tierno Mb, Turner M, Bennett Jp, Lau A, Howard S. Hochster> ;Journal of the National Cancer Institute. 2020 Nov 1
• 5 citations
  Factors associated with MRI detection of occult lesions in newly diagnosed breast cancers.
  Julie S. Wecsler, Young Ju Jeong, Akshara Singareeka Raghavendra, Wendy J. Mack, Debasish Tripathy, Mary Yamashita, Pulin Sheth, Linda Hovanessian Larsen, Christy A. R...> ;Journal of Surgical Oncology. 2020 Mar 1
• 44 citations
  Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer.
  Philip D. Poorvu, Shari Gelber, Shoshana M. Rosenberg, Kathryn J. Ruddy, Rulla M. Tamimi, Laura C. Collins, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Ste...> ;Journal of Clinical Oncology. 2020 Mar 1
• Correction to: Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology.
  Danielle M. Bello, Christy A. Russell, Debbie McCullough, Marni Tierno, Monica Morrow> ;Annals of Surgical Oncology. 2018 Dec 1
• 23 citations
  Clinical relevance of the 21-gene Recurrence Score® assay in treatment decisions for patients with node-positive breast cancer in the genomic era
  Eleftherios P. Mamounas, Christy A. Russell, Anna Lau, Michelle Turner, Kathy S. Albain> ;NPJ Breast Cancer. 2018 Aug 20
• 22 citations
  Lymph Node Status in Breast Cancer Does Not Predict Tumor Biology.
  Danielle M. Bello, Christy A. Russell, Debbie McCullough, Marni Tierno, Monica Morrow> ;Annals of Surgical Oncology. 2018 Jul 2
• 134 citations
  Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.
  Cynthia X. Ma, Ron Bose, Feng Gao, Rachel A. Freedman, Melinda L. Telli, Gretchen Kimmick, Eric P. Winer, Michael Naughton, Matthew P. Goetz, Christy A. Russell, Debu ...> ;Clinical Cancer Research. 2017 Oct 1
• 10 citations
  The tipping point: Tamoxifen toxicity, central serous chorioretinopathy, and the role of estrogen and its receptors.
  Nicole Koulisis, Stavros N. Moysidis, Lisa C. Olmos de Koo, Christy A. Russell, Amir H. Kashani> ;American Journal of Ophthalmology Case Reports. 2016 Oct 1
• 2 citations
  Value of routine staging imaging studies for patients with stage III breast cancer.
  Caroline I. Piatek, Lingyun Ji, Chandan Kaur, Christy A. Russell, Debu Tripathy, Terry David Church, Richard Sposto, Stephen F. Sener, Agustin A. Garcia> ;Journal of Surgical Oncology. 2016 Sep 19
• 92 citations
  Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.
  Yongli Ji, Cathryn Rankin, Steven M. Grunberg, Andy Sherrod, Jamshid Ahmadi, Jeannette J. Townsend, Lynn G. Feun, Ruth K. Fredericks, Christy A. Russell, Fairooz F. Ka...> ;Journal of Clinical Oncology. 2015 Nov 2
• 27 citations
  Double-blind randomized 12-month soy intervention had no effects on breast MRI fibroglandular tissue density or mammographic density
  Anna H. Wu, Darcy V. Spicer, Agustin A. Garcia, Chiu-Chen Tseng, Linda Hovanessian-Larsen, Pulin Sheth, Sue Ellen Martin, Debra Hawes, Christy A. Russell, Heather R. M...> ;Cancer Prevention Research. 2015 Oct 1
• 15 citations
  Lymph node status in inflammatory breast cancer
  Julie S. Wecsler, Welela Tereffe, Rose C. Pedersen, Michelle R. Sieffert, Wendy J. Mack, Haiyan Cui, Christy A. Russell, Ryan R. Woods, Rebecca K. Viscusi, Stephen F. ...> ;Breast Cancer Research and Treatment. 2015 Apr 7
• Molecular profiling for DCIS.
  Christy A. Russell> ;Clinical Advances in Hematology & Oncology. 2014 Sep 1
• 4 citations
  Personalized medicine for breast cancer: it is a new day!
  Christy A. Russell> ;American Journal of Surgery. 2014 Mar 1
• 6 citations
  Treatment effect of capecitabine and docetaxel or docetaxel alone by oestrogen receptor status in patients with metastatic breast cancer: Results of an exploratory ana...
  Stefan Glück, C. Russell, Joyce O'Shaughnessy, EF McKenna, S Hu, Dawn Odom, Joanne L. Blum> ;Breast. 2013 Dec 1
• 10 citations
  Ductal carcinoma in situ (DCIS) of the breast: Perspectives on biology and controversies in current management
  Isaac Schmale, Stephen V. Liu, Jessica Rayhanabad, Christy A. Russell, Stephen F. Sener> ;Journal of Surgical Oncology. 2012 Feb 1
• 19 citations
  A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer
  George Somlo, C. Martel, S. Lau, Paul Frankel, Christopher Ruel, Long Gu, Arti Hurria, C Chung, T Luu, Robert J. Morgan, Lucille Leong, Marianna Koczywas, Mark McNamar...> ;Breast Cancer Research and Treatment. 2012 Feb 1
• 2 citations
  The role of albumin-bound paclitaxel in metastatic breast cancer.
  Christy A. Russell> ;Clinical Advances in Hematology & Oncology. 2011 Jun 1
• 29 citations
  Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer
  Andrew D. Seidman, Adam Brufsky, Rafat Ansari, Lowell L. Hart, R. S. Stein, Lee S. Schwartzberg, J. F. Stewart, C.A. Russell, S-C Chen, L.E. Fein, J.A. De La Cruz Varg...> ;Annals of Oncology. 2011 May 1
• 58 citations
  Phase III Comparison of Standard Doxorubicin and Cyclophosphamide Versus Weekly Doxorubicin and Daily Oral Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor ...
  Georgiana K. Ellis, William E. Barlow, Julie R. Gralow, Gabriel N. Hortobagyi, Christy A. Russell, Melanie Royce, Edith A. Perez, Danika Lew, Robert B. Livingston> ;Journal of Clinical Oncology. 2011 Mar 10
• Join now to see all